Source Normalized Impact per Paper (SNIP):2016: 0.567SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.

Impact per Publication (IPP): 0.588

Impact per Publication (IPP):2016: 0.588The Impact per Publication measures the average number of citations received in a particular year by papers published in the journal during the three preceding years.

SCImago Journal Rank (SJR): 0.277

SCImago Journal Rank (SJR):2016: 0.277SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.

Cite Score: 0.51

Cite Score:2016: 0.51CiteScore metrics are a new standard to measure serial citation impact.

A NEED OF BETTER PHARMACOVIGILANCE SYSTEM IN INDIA

Prajakta Pradeep Masurkar

Abstract

India is one of the top producers of generics globally and is currently being recognized as the “pharmacy of the world” for the generic drug products. Thus, there is a need that it has best health-care systems in place to regulate and provide better quality drugs by monitoring the possible risk associated with the use of drugs. Being the generic hub, physicians, pharmacists, etc., should be erudite to provide an alternative cost-effective generic medicine, which is one of the education-related aspects of pharmacovigilance. We need a more systematic approach to surveillance of drug-related problems, which is at the heart of pharmacovigilance. The health-care system requires new processes to understand the risk-benefit ratio of drugs. The challenges in implementation of better pharmacovigilance in country due to nonavailability of trained staff in pharmacovigilance, lack of training of health-care professionals on drug safety, and adverse drug reaction reporting which comprises adverse interactions of medicines with chemicals, other medicines, and food are often neglected leading to under-reporting by health-care professionals as well as patients, lack of expertise, etc., should be overcome by Indian regulatory body via practical oriented knowledge-based system. The web market monitoring, global electronic database, education, association of stakeholders and regulation of herbal medicines standards and allied medicinal systems are vital restructurings needed to be introduced for a better pharmacovigilance system in India.

Report of CIOMS (Council for International Organisations of Medical Sciences) Working Group III. Guidelines for Preparing Core Clinical- Safety Information on Drugs. Geneva: Council for International Organisations of Medical Sciences; 1995.

CIOMS Working Group VIII. Practical Aspects of Signal Detection in Pharmacovigilance. Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2010.